525
  • Executive interview - Race Oncology

    811 views 2 years ago
    Race Oncology is developing bisantrene, which had been the subject of over 40 clinical trials in the 1980s and 1990s as part of Lederle’s search for a safer anthracycline chemotherapy. Despite positive responses in a variety of cancers, especially AML (it was even approved for the treatment of AML in France, but never commercialised), development stopped after Lederle was sold to Wyeth and then Wyeth to Pfizer. Race will be developing bisantrene initially for relapsed/refractory AML and expects to start a pivotal trial for approval in the US around the end of 2018. Show less
    Read more
  • Uploads Play all

    • Executive interview – VolitionRx - Duration: 7 minutes, 16 seconds.

      • 4 days ago
      • 37 views
      VolitionRx is a multinational epigenetics company developing simple, easy-to-use, cost-effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potentia...
    • Bitesize briefing – Renergen - Duration: 11 minutes, 17 seconds.

      • 6 days ago
      • 75 views
      In this video Ian McLelland discusses his visit to Renergen’s facilities in the Free State, South Africa in early February. The visit took in Renergen’s gas processing facilities, ongoing drilling ...
    • Executive interview – Treatt - Duration: 8 minutes, 35 seconds.

      • 6 days ago
      • 54 views
      Treatt’s clean-label innovations continue to resonate with consumer demand for better-for-you/natural products, as consumers continue to look for premium beverage propositions with positive health ...
    • Executive interview – Therapin - Duration: 6 minutes, 40 seconds.

      • 2 weeks ago
      • 3 views
      THERAPiN is a global pharma-grade medical cannabis company that is based in Israel. It is a fully integrated firm, licensed for breeding, farming, manufacturing and distribution, which is creating ...
    • Executive interview – Britvic - Duration: 2 minutes, 59 seconds.

      • 2 weeks ago
      • 8 views
      Britvic is a soft-drink beverage company with headquarters in the UK. It also has operations in France, Brazil and selected other EU markets. The company has a strong portfolio of its own brands, i...
    • Executive interview – Securities Trust of Scotland - Duration: 5 minutes, 24 seconds.

      • 2 weeks ago
      • 7 views
      Securities Trust of Scotland (LSE:STS) was launched in 2005, and aims to provide rising income and long-term capital growth through a portfolio of global equities. In May 2016, Mark Whitehead was a...
    • Executive interview – Immunicum - Duration: 4 minutes, 50 seconds.

      • 3 weeks ago
      • 20 views
      Immunicum is a clinical-stage immunoncology company based in Stockholm, Sweden. The company is developing an allogeneic off-the-shelf dendritic cell immune activator (immune primer) for use in comb...
    • Executive interview – Cantargia - Duration: 4 minutes, 59 seconds.

      • 4 weeks ago
      • 237 views
      Cantargia is a clinical-stage biotechnology company based in Sweden, established in 2009 and listed on the Nasdaq Stockholm main market. It is developing two assets against IL1RAP, CAN04 and CAN10....
    • Bitesize briefing – Alaska’s North Slope - Duration: 3 minutes, 49 seconds.

      • 4 weeks ago
      • 7 views
      In this video, we look at Alaska’s North Slope, an area of renewed industry interest. In particular, we focus on Charlie-1, a potentially high-impact well targeting gross prospective resources of 1...
    • Executive interview – Ilika - Duration: 6 minutes, 7 seconds.

      • 1 month ago
      • 35 views
      Ilika is a pioneer in solid-state battery technology. In this interview, CEO Graeme Purdy discusses the progress being made on Ilika’s miniaturised Stereax products for medical and Industrial Inter...
    • Executive interview - Sureserve (full) - Duration: 3 minutes, 11 seconds.

      • 1 month ago
      • 32 views
      In Sureserve's latest ETV, executive chairman Bob Holt speaks about the turnaround being delivered at the company. The group reported earnings ahead of expectations on 21 January, with this the fir...
    This item has been hidden
  • This item has been hidden
to add this to Watch Later

Add to

Loading playlists...